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EBSJ is proud to present a selection of significant presentations made by investigators of the AOSpine North America community at the 11th Annual AOSNA Fellow meeting in Banff, Alberta. These studies demonstrate the bandwidth of research going on in AOSpine, ranging from basic sciences, population studies, and clinical outcomes projects to unprecedented, internationally linked research to solve major questions regarding surgical oncology. Congratulations to the authors and best wishes on their road to final publication!
